{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-007965","form_type":"8-K","ticker":"BIAF","cik":"0001712762","company_name":"bioAffinity Technologies, Inc.","filed_at":"2026-02-25T23:59:59+00:00","discovered_at":"2026-05-14T18:02:35.978055+00:00","generated_at":"2026-05-16T00:22:06.595298+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"bioAffinity Technologies announces validation study with Brooke Army Medical Center for CyPath Lung test","bullets":["Study with BAMC to validate CyPath Lung on sputum obtained by tracheal/bronchial suctioning for early lung cancer detection.","Enrolling 30-50 patients; results expected by mid-2026.","Potential to expand sample collection options; currently patients collect sputum at home.","U.S. bronchoscopy procedures ~500,000 annually; market valued at $700-920M."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-007965","json":"https://secwatch.observer/filing/0001493152-26-007965.json","markdown":"https://secwatch.observer/filing/0001493152-26-007965.md","text":"https://secwatch.observer/filing/0001493152-26-007965.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1712762/000149315226007965/0001493152-26-007965-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1712762/000149315226007965/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T00:22:06.595298+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}